Francois Dufresne Appointed to Noodles & Company Board of Directors
Mar 07, 2016 21:05 pm UTC| Business
BROOMFIELD, Colo., March 07, 2016 -- Noodles Company (NASDAQ:NDLS) today announced the appointment of François Dufresne, Senior Director at the Public Sector Pension Investment Board ("PSP Investments"), to its Board...
Five9 to Present at the 28th Annual ROTH Conference on March 15, 2016
Mar 07, 2016 21:05 pm UTC| Business
SAN RAMON, Calif., March 07, 2016 -- Five9, Inc. (NASDAQ:FIVN), a leading provider of cloud software for the enterprise contact center market, announced today that members of its management team will present at the 28th...
Vical Announces News Release and Conference Call Schedule for Fourth Quarter 2015 Financial Results
Mar 07, 2016 21:05 pm UTC| Business
SAN DIEGO, March 07, 2016 -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and twelve months ended December 31, 2015, before the opening of trading on...
Heat Biologics Presents Positive ComPACT Preclinical Data at the Keystone Symposia
Mar 07, 2016 21:05 pm UTC| Business
DURHAM, N.C., March 07, 2016 -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer, announced that positive...
Mar 07, 2016 21:05 pm UTC| Business
PITTSBURGH, March 07, 2016 -- II‐VI Incorporated (NASDAQ:IIVI), a leading provider of solutions for next generation optical networks, today announced that it is ramping up shipments of low noise optical amplifiers with...
Opiant Pharmaceuticals, Inc., Announces Ticker Symbol Change to “OPNT”
Mar 07, 2016 21:05 pm UTC| Business
SANTA MONICA, Calif., March 07, 2016 -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders,...
TRACON Pharmaceuticals Reports Granting of Inducement Awards
Mar 07, 2016 21:05 pm UTC| Business
SAN DIEGO, March 07, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...